Publicacions
-
Jutel, M, Torres, MJ, Palomares, O, Akdis, CA, Eiwegger, T, Untersmayr, E, Barber, D, Zemelka-Wiacek, M, Kosowska, A, Palmer, E, Vieths, S, Mahler, V, Canonica, WG, Nadeau, K, Shamji, MH, Agache, I, Akdis, M, Khaitov, M, Alvarez-Perea, A, Alvaro-Lozano M, Atanaskovic-Markovic, M, Backer, V, Barbaud, A, Bavbek, S, de Blay, F, Bonini, M, Bonini, S, van Boven, JFM, Brockow, K, Cazzola, M, Chatzipetrou, A, Chivato, T, Cianferoni, A, Corren, J, Cristoph-Caubet, J, Dunn-Galvin, A, Ebisawa, M, Firinu, D, Gawlik, R, Gelincik, A, del Giacco, S, Mortz, CG, Hoffmann, HJ, Hoffmann-Sommergruber, K, Klimek, L, Knol, E, Lauerma, A, de Llano, LP, Matucci, A, Meyer, R, Moreira, A, Morita, H, Patil, SU, Pfaar, O, Popescu, FD, del Pozo, V, Price, OJ, van Ree, R, Fernandez-Rivas, M, Rogala, B, Romano, A, Santos, A, Sediva, A, Skypala, I, Smolinska, S, Sokolowska, M, Sturm, G, Vultaggio, A, Walusiak-Skorupa, J and Worm, M.
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations
ALLERGY . 77(8): 2313-2336. Nº de cites: 15
-
Zuberbier T, Dörr T, Aberer W, Alvaro-Lozano M, Angier E, Arasi S, Arshad H, Ballmer-Weber B, Bartra J, Beck L, Bégin P, Bindslev-Jensen C, Bislimovska J, Bousquet J, Brockow K, Bush A, Cianferoni A, Cork MJ, Custovic A, Darsow U, de Jong N, Deleanu D, Del Giacco S, Deschildre A, Dunn Galvin A, Ebisawa M, Fernández-Rivas M, Ferrer M, Fiocchi A, Gerth van Wijk R, Gotua M, Grimshaw K, Grünhagen J, Heffler E, Hide M, Hoffmann-Sommergruber K, Incorvaia C, Janson C, Malte John S, Jones C, Jutel M, Katoh N, Kendziora B, Kinaciyan T, Knol E, Kurbacheva O, Lau S, Loh R, Lombardi C, Mäkelä M, Marchisotto MJ, Makris M, Maurer M, Meyer R, Mijakoski D, Minov J, Mullol J, Nilsson C, Nowak-Wegrzyn A, Nwaru BI, Odemyr M, Pajno GB, Paudel S, Papadopoulos NG, Renz H, Ricci G, Ring J, Rogala B, Sampson H, Senna G, Sitkauskiene B, Smith PK, Stevanovic K, Stoleski S, Szajewska H, Tanaka A, Todo-Bom A, Topal FA, Valovirta E, Van Ree R, Venter C, Wöhrl S, Wong GWK, Zhao Z and Worm M.
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA2LEN position paper
ALLERGY . 77(6): 1736-1750. Nº de cites: 19
-
Rodríguez Del Río P, Alvarez-Perea A, Blumchen K, Caimmi D, Caubet JC, Konstantinopoulos AP, Riggioni C, Fassio F, Karakoc-Aydiner E, Le TM, Patel N, Savolainen J, Vazquez-Ortiz M and Alvaro-Lozano M.
Food immunotherapy practice: Nation differences across Europe, The FIND project
ALLERGY . 77(3): 920-932. Nº de cites: 9
-
Alvaro-Lozano M, Mónica Paola Sandoval Ruballos, Giovannini M, Jensen-Jarolim E, Sahiner U, Tomic Spiric V, Quecchia C, Chaker A, Heffler E, Klimek L, Brough H, Sturm G, Untersmayr E, Bonini M and Pfaar O.
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey
Clinical and Translational Allergy . 12(1): . Nº de cites: 13
-
Tsabouri S, Arasi S, Beken B, Church MK, Alvaro-Lozano M, Caffarelli C, Flohr C, Janmohamed SR, Konstantinou GN, Lau S, Lefevre S, Mortz CG, Pajno G, Pite H, Rutkowski K, Staubach P, Van der Poel LA, Zuberbier T and Leslie TA.
A European survey of management approaches in chronic urticaria in children: EAACI pediatric urticaria taskforce
PEDIATRIC ALLERGY AND IMMUNOLOGY . 33(1): . Nº de cites: 5
-
de Silva D, Singh C, Arasi S, Muraro A, Zuberbier T, Ebisawa M, Alvaro-Lozano M and Roberts G.
Efficacy and safety of biological therapies for children and adults with IgE-mediated food allergy: systematic review
Authorea . : .
-
Pfaar O, Agache I, Bonini M, Brough HA, Chivato T, Del Giacco SR, Gawlik R, Gelincik A, Hoffmann-Sommergruber K, Jutel M, Klimek L, Knol EF, Lauerma A, Ollert M, O'Mahony L, Mortz CG, Palomares O, Riggioni C, Schwarze J, Skypala I, Torres MJ, Untersmayr E, Walusiak-Skorupa J, Chaker A, Giovannini M, Heffler E, Jensen-Jarolim E, Quecchia C, Mónica Paola Sandoval Ruballos, Sahiner U, Tomic Spiric V and Alvaro-Lozano M.
COVID-19 pandemic and allergen immunotherapy-an EAACI survey
ALLERGY . 76(11): 3504-3516. Nº de cites: 33
-
Escarrer-Jaume M, Julia JC, Quevedo-Teruel S, Prieto Del-Prado A, Mónica Paola Sandoval Ruballos, Quesada-Sequeira F and Alvaro-Lozano M.
Changes in epidemiology and clinical practice in IgE-mediated allergy in children
ANALES DE PEDIATRIA . 95(1): . Nº de cites: 2
-
Arasi S, Pajno GB, Panasiti I, Sandoval M and Alvaro-Lozano M.
Allergen Immunotherapy in children with respiratory allergic diseases
Minerva Pediatrica . 72(5): 343-357. Nº de cites: 6
-
Brough HA, Kalayci O, Sediva A, Untersmayr E, Munblit D, Rodriguez Del Rio P, Vazquez-Ortiz M, Arasi S, Alvaro-Lozano M, Tsabouri S, Galli E, Beken B and Eigenmann PA.
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics
PEDIATRIC ALLERGY AND IMMUNOLOGY . 31(5): 442-448. Nº de cites: 90